韩国的药品政策和医药分离

1∗1Davis19972000200071∗SoonmanKwon22.2.160%120001Kwon(2003c,2005)32.250%40%MOHW200043.7%45.4%431%20%200427.4%11OECD(2006)2090KwonReich20053.23.125200061.5%1718738.5%10775MOHW,20003.23.363.43.562%8%11%60.583.983.986.48.125.552.461.7*NationalHealthInsuranceCorporation(NHIC),TrendinHealthCareprovisioninHealthInsurance,1997(inKorean)74.Jacobs1992KwonReich200510%physician8fees44%32001Kwon2007450DRGKwon2003b5.KIHASA2002a95.15%2001314440034%2001KHA20019200292.99%92.64%2455.057.546.18200215.5857.72%45.06%30%80%6220001200112002195.15%92.99%92.64%5.05days6.18days7.54days6.185.705.5857.72%51.47%45.06%*29.80%37.48%38.54%KoreaInstituteforHealthandSocialAffairs(KIHASA),EvaluationoftheSeparationofDrugPrescribingandDispensing,2002*/[phone]%20%200012001200215200160.3310.064DDD/1000/-2.1641.411DDD/1000/36%286%0.0390.073DDD/1000/1062%7200029.80%200137.48%2002138.54%3Hellerstein1998Lundin200071119992000118.7%(KIHASA2002b)172.8%1020814NHIC200361%31%KIHASA2002b6.420065positivelisting122NationalHealthInsuranceCorporation20076.1765%7NHIC1380%185%68%25185%-6.2negativelisting2006121740146.3HIRA157.16RodwinOkamoto200040%Ikegami2003ChouYip2001